Literature DB >> 3280841

Experience with single-lung transplantation for pulmonary fibrosis. The Toronto Lung Transplant Group.

.   

Abstract

Repeated success has now been obtained with single-lung transplantation for end-stage pulmonary fibrosis. Potential candidates for this procedure are individuals who are less than 60 years of age and who have progressive pulmonary deterioration with limited life expectancy. Since November 1983, eleven such transplantations have been performed; nine patients achieved discharge from the hospital and eight patients have remained alive up to 44 months after surgery. All of these recipients have good oxygenation on room air and good exercise tolerance and are capable of performing routine activities, including a return to previous employment. From our experience, it appears likely that single-lung transplantation can achieve the same success rates as other major organ transplantations.

Entities:  

Mesh:

Year:  1988        PMID: 3280841

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  5 in total

Review 1.  Emerging indications for the use of cyclosporin in organ transplantation and autoimmunity.

Authors:  P A Keown
Journal:  Drugs       Date:  1990-09       Impact factor: 9.546

2.  Effect of a single injection of high-dose FK506 on lung transplantation in rats.

Authors:  Y Sano; S Maruyama; M Aoe; H Date; N Shimizu
Journal:  Surg Today       Date:  1996       Impact factor: 2.549

Review 3.  Lung transplantation.

Authors:  L T Tanoue
Journal:  Lung       Date:  1992       Impact factor: 2.584

Review 4.  Heart-lung and lung transplantation for cystic fibrosis.

Authors:  N Lewiston; V Starnes; J Theodore
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

5.  Spirometric assessment of lung transplant patients: one year follow-up.

Authors:  Paulo M Pêgo-Fernandes; Fernando Conrado Abrão; Frederico Leon Arrabal Fernandes; Marlova L Caramori; Marcos Naoyuki Samano; Fabio B Jatene
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.